Skip to main content

Table 1 General characteristics of the study participants

From: FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran

Variables

Values

Age (years) mean ± SD

42.95 ± 10.97

Gender N (%)

 Male

144 (70.2)

 Female

61 (29.8)

AST (U/L) mean ± SD

44.75 ± 22.58

ALT (U/L) mean ± SD

51.57 ± 43.37

Platelet count (/µL) mean ± SD

236,414.63 ± 91,908.84

FibroScan score (kPa) mean ± SD

8.70 ± 5.43

CAP score (dB/m) mean ± SD

307.33 ± 47.62

APRI mean ± SD

0.629 ± 0.661

FIB-4 mean ± SD

1.45 ± 1.27

AST/ALT ratio mean ± SD

0.92 ± 0.25

FibroScan results N (%)

 F1

94 (45.9)

 F2

67 (32.7)

 F3

29 (14.1)

 F4

15 (7.3)

  1. N number, SD standard deviation, AST aspartate aminotransferase, ALT alanine aminotransferase, CAP controlled attenuation parameter, APRI AST to platelet ratio index, FIB-4 fibrosis-4
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us